 Yttrium (90Y) tacatuzumab tetraxetan

Yttrium (90Y) tacatuzumab tetraxetan is a radiopharmaceutical used in targeted radiotherapy, particularly for the treatment of certain types of cancers. In this compound: - **Yttrium-90 (90Y)**: This is a radioactive isotope of yttrium that emits beta particles, which can destroy cancer cells. Its radioactive properties make it effective for therapeutic purposes.